Thus, it may be of therapeutic value to preserve beta cells across all clinical stages of type 1 diabetes progression, to mitigate the deterioration of beta cell morphology (i.e. size) and identity (i.e. insulin and PC1/3 co-localisation, and insulin content). The gene discussed is INS; the disease is type 1 diabetes mellitus.